Skip to content
Intra Mesk Pharma — انترا مسك فارما

Regulatory Affairs

Regulatory Readiness Through Structured Coordination

Regulatory requirements are an essential part of bringing healthcare products to market and maintaining their appropriate status over time.

Intra Mesk Pharma approaches regulatory affairs through structured assessment, documentation, coordination and follow-up, with the pathway adapted to the product, its regulatory status and the requirements applicable to its specific circumstances.

Why Readiness Matters

Regulatory Readiness Comes Before Regulatory Execution

A clear regulatory pathway begins with understanding the product and its regulatory position.

Before a regulatory activity is undertaken, relevant information should be identified, documentation should be reviewed and the applicable requirements should be understood.

This helps establish a structured basis for regulatory coordination and reduces the risk of treating different products as though they follow the same pathway.

This function operates inside the company-wide Operating Protocol — the protocol describes the whole cycle; this page zooms into one specialist layer.

The Regulatory Framework

A Structured Regulatory Framework

Six connected parts, from product status to lifecycle maintenance. Open any part to see what it covers.

  1. Understanding the current regulatory status and relevant product information.

This framework is a public description of how regulatory readiness is organized — not legal advice, and not a description of internal procedures.

The Decision Model

Regulatory Pathways Are Product-Specific

The applicable regulatory process depends on the nature and status of the product.

Different product categories may require different documentation, regulatory mechanisms, import arrangements or ongoing obligations.

Pick a question

The question

Is the product already registered?

Registration status shapes which routes exist at all — a registered product and an unregistered one do not follow the same path.

  • ClearContinue

    The answer is clear — the case can move forward along the current path.

  • UnclearClarify

    The answer is unclear — the question is resolved through clarification before proceeding.

  • Not readyPrepare

    Something is missing — preparation and completion come first.

  • Different statusFollow the applicable pathway

    The case carries a different status — and follows the pathway that applies to it.

For this reason, regulatory assessment begins with the product rather than with a predetermined pathway.

Document Readiness

Documentation Is Part of Regulatory Readiness

Regulatory readiness depends on having relevant product information and supporting documentation available, organized and maintained appropriately.

Documentation should support the product's identified regulatory pathway and remain connected to the activities and decisions associated with that pathway.

The objective is not documentation for its own sake. It is to maintain a reliable information base for regulatory coordination and ongoing product management.

  1. F-01

    Identity

    Who the product is — its name, its form and its identifying information.

  2. F-02

    Status

    Where it stands — registration and regulatory status.

  3. F-03

    Technical Information

    What it is and how it is characterized, at the level the applicable pathway requires.

  4. F-04

    Legal / Commercial Documentation

    The arrangements that allow the product to be represented and supplied.

  5. F-05

    Applicable Supporting Records

    The supporting records the applicable pathway calls for.

The exact composition of any file depends on the product and the applicable pathway — this is a readiness concept, not a document list.

Cross-Functional Coordination

Regulatory Coordination Requires Clarity

Effective coordination depends on clear responsibilities, accurate information and timely communication.

Within its scope, Intra Mesk Pharma coordinates relevant regulatory information and activities with the appropriate internal functions, manufacturers or suppliers, and regulatory stakeholders as applicable.

The exact nature of the coordination depends on the product, the applicable pathway and the responsibilities established for the specific arrangement.

Commercial

Quality

Supply

Partner

Regulatory

The Submission Lifecycle

The regulatory function's own lifecycle

Distinct from the company-wide Operating Protocol: this is the path a regulatory case itself travels — including the clarification loop where most of the real work happens.

  1. 01

    Assess

    The case is read before anything moves.

  2. 02

    Prepare

    Documentation is organized to the standard the process requires.

  3. 03

    Submit · Coordinate

    Where applicable, the process is engaged with the relevant authority.

  4. 04

    Follow up

    Progress is tracked and requests are received.

    Clarification loop — repeat as the case requires

  5. 05

    Respond · Clarify

    Clarifications and responses are compiled and returned.

  6. 06

    Update

    The file is updated as the case develops.

  7. 07

    Maintain

    The product's regulatory position is kept current.

Submission is not the end

Regulatory work often continues through follow-up, clarification, updates, maintenance activities, and coordination related to the product's ongoing status. No timelines are promised — and none are implied.

Market Entry & Import

The Applicable Entry Mechanism Depends on the Situation

Healthcare products may be subject to different import and market-entry mechanisms depending on their regulatory status, product category and applicable requirements.

No single route is presented here as universally applicable — the applicable combination is assessed per product.

What the applicable mechanism can involve

  • Applicable regulatory requirements
  • Applicable import mechanism
  • Authority coordination
  • Required documentation
  • Product status and circumstances

Commercial & agency arrangements

Where applicable, commercial and agency arrangements may require coordination with the relevant authorities and registration mechanisms. No fixed sequence applies to every case, and no deadlines are published.

The regulatory environment

Regulatory coordination may involve interaction with the relevant health and pharmaceutical regulatory authorities according to the product and applicable pathway. Authority decisions rest with the authorities — not with Intra Mesk Pharma.

References are informational and do not constitute legal advice.

Why Registration Matters

Unregistered products are a risk — never a bargain.

Product registration is the national verification that a product is known, evaluated and permitted for use in Yemen. Our position is unambiguous — if it is not registered, it does not move through our supply chain.

A Carefully Qualified Note

Exceptional or special pathways

Where an exceptional or special pathway is legally available, it must be treated as a specific regulatory mechanism subject to the applicable requirements and authorization.

Such a pathway does not automatically replace the product's continuing regulatory obligations.

  • Availability of such a pathway is not assumed — it depends on law and circumstance.
  • Qualification is assessed per product and per case.
  • Authorization is never guaranteed.
  • This is not legal advice.

Authorities

The health and pharmaceutical regulatory authorities relevant to the product and pathway.

Intra Mesk Pharma

Regulatory affairs — carrying readiness, coordination and follow-up in both directions.

Manufacturer / Partner

The party behind the product and its documentation.

Two Directions

Regulatory coordination works in two directions

Information, clarifications, document requests, follow-up and status communication all move across the regulatory function — outward to the authorities and back to the relevant parties, in both directions.

  • Information flows

    Product, status and documentation information moves in both directions.

  • Clarification flows

    Questions travel out and answers travel back.

  • Document requests

    Requests for documents are received, compiled and responded to.

  • Follow-up

    Cases are followed until they reach an outcome.

  • Status communication

    The relevant parties stay informed of where the product stands.

Our team brings hands-on experience managing registration files and regulatory coordination with the competent drug authorities, including the Supreme Board of Drugs and Medical Appliances (SBDMA) in Sana'a and its counterpart in Aden — operating within their mandates, never instead of them.

After Market Entry

Regulatory Affairs Continue After Market Entry

Regulatory responsibility does not necessarily end when a product enters the market.

Relevant information may need to remain current, and applicable changes, renewals, updates, product information and regulatory communications may require follow-up over time.

  • Maintaining relevant product information
  • Regulatory updates
  • Changes requiring review
  • Coordination with manufacturers and suppliers
  • Ongoing product status monitoring
  • Post-market regulatory support where applicable

Our regulatory approach therefore considers both market-entry readiness and ongoing regulatory maintenance within the responsibilities applicable to the product.

Who Works With Regulatory Affairs?

Manufacturers & SuppliersInternal Commercial TeamsQualitySupply & OperationsRelevant AuthoritiesHealthcare Stakeholders where applicable

Coordination with authorities is conducted within their mandates — Intra Mesk Pharma does not exercise authority over regulators, and internal contacts are not published.

The Public Interest

Why Regulatory Discipline Matters

Regulatory discipline supports a more controlled relationship between products, documentation, supply processes and healthcare requirements.

For healthcare professionals, organizations, manufacturers, suppliers and institutional stakeholders, clearer regulatory readiness helps provide a more structured basis for product movement and ongoing management.

Discuss a Regulatory Requirement

Our regulatory approach is designed to bring clarity to product status, documentation, applicable requirements and coordination, while recognizing that every product must be assessed according to its own circumstances.